Browse Articles

Discover research articles across all indexed journals

A biosensor platform for scalable and live detection of PYY hormone production from enteroendocrine cells with single-event resolution

Journal of Biological Chemistry Aanya Hirdaramani, Gary Frost, Aylin C. Hanyaloglu Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113367

Anthracycline-free platinum-based neoadjuvant chemotherapy in operable triple-negative breast cancer: Interim analysis of pathologic complete response rates and predictors of response.

Journal of Clinical Oncology Evgeniya Ratova, Larisa Bolotina, Tatiana Ustinova Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.34

34 Background: Neoadjuvant chemotherapy (NACT) remains the cornerstone of treatment for operable triple-negative breast cancer (TNBC), with pathologic complete response (pCR) regarded as a key surrogate marker of long-term outcomes. Although platinum-based regimens are associated with higher pCR rates, the optimal composition of neoadjuvant therapy, including the role of anthracyclines, has not been definitively established. In this context, data on the feasibility and efficacy of anthracycline-free platinum-based NACT in routine clinical practice remain limited. Methods: This prospective single-center interim analysis included 52 patients with stage II–III TNBC who received anthracycline-free platinum-based NACT consisting of carboplatin combined with weekly paclitaxel. The primary endpoint was pCR (ypT0/is ypN0). Treatment delivery and clinicopathologic predictors of pCR were assessed using univariate logistic regression analysis. Results: Pathologic complete response was achieved in 30 of 52 patients, corresponding to a pCR rate of 57.7%. The presence of a germline BRCA1/2 mutation was significantly associated with a higher likelihood of achieving pCR (OR 6.67; 95% CI 1.31–33.92; p = 0.022). A higher Ki-67 proliferation index was also associated with increased probability of pCR (OR 1.07 per 1% increase; 95% CI 1.02–1.12; p = 0.006). Stromal tumor-infiltrating lymphocytes (TILs) ≥20% demonstrated a trend toward higher pCR rates but did not reach statistical significance. Chemotherapy dose reductions occurred in 42.3% of patients, including carboplatin (40.4%) and paclitaxel (28.8%). Median dose reductions among affected patients were 15% and 25%, respectively. Neither chemotherapy dose reductions nor treatment delays were associated with a decreased likelihood of achieving pCR. Conclusions: Anthracycline-free platinum-based NACT demonstrated a clinically meaningful pCR rate in operable TNBC with preserved treatment delivery despite frequent dose modifications. Germline BRCA1/2 mutations and high Ki-67 were associated with an increased probability of pCR, whereas the predictive value of TILs remains limited and requires validation in larger cohorts. These findings support the feasibility of anthracycline-free platinum-based regimens and may inform patient selection.

Atomic Alignment in PbS Nanocrystal Superlattices with Compact Inorganic Ligands via Reversible Oriented Attachment of Nanocrystals

Journal of the American Chemical Society Ahhyun Jeong, Aditya N. Singh, Josh Portner et al. Jul 01, 2026 DOI: 10.1021/jacs.6c00744

Engineering internally His-tagged ESX secretion system fusion antigens for tuberculosis nanoparticle vaccines

Journal of Biological Chemistry Wen-Ling Hsu, Yang Jiao, Wei-Chiao Huang et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113337

Genetic spectrum of cancer susceptibility: Insights from a 6,093-patient real-world cohort in Singapore.

Journal of Clinical Oncology Mengyuan Yang, Jianbang Chiang, Zewen Zhang et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.171

171 Background: Compared to populations of European-descent, prevalence of pathogenic germline variants in cancer predisposition genes is poorly-defined in Asian populations. Here, we investigate genetic spectrum in cancer susceptibility in the Singapore real-world cancer cohort. Methods: The cancer cohort comprised patients referred to Cancer Genetics Service at the National Cancer Center Singapore (Feb 2014-Nov 2025), who underwent multi-gene panel testing. Predictive testing cases were excluded and only the probands were analyzed. Demographics, medical/family history, and genetic results were prospectively collected via REDCap (v13.1.30). Results: The cohort (N=6093) included Chinese (n=4601, 75.5%), Malay (n=516, 8.5%), and Indian (n=358, 5.9%) patients. Predominant diagnoses were breast (3477/6093, 57.1%) and ovarian (998/6093, 16.4%) cancers. Multiple cancers occurred in 11.6% (707/6093), of which 17.5% (124/707) had combined breast and ovarian cancers. Overall, 19.6% (1195/6093) were positive variant (PV) carriers, primarily in BRCA2 (17.7%), BRCA1 (16.2%), and PALB2 (4.4%). PV rates varied significantly: Chinese patients (18.1%) had lower rates compared to Malay (24.0%, p=0.0035) and Indian patients (24.6%, p=0.0078), with no significant difference between the latter two (p>0.05). Among 669 patients with variant reclassification, 61 (9.1%) novel PV carriers were identified, primarily upgraded from VUS. With a median time to reclassification of 1.55 years, upgraded PVs were most frequently observed in BRCA1 (18.0%), ATM (11.5%), MLH1 (9.8%), and POLE (9.8%). Crucially, 16 pedigrees pursued cascade testing, identifying 33 asymptomatic PV carriers who subsequently became eligible for high-risk surveillance. Conclusions: Leveraging Asia's largest multi-ethnic hereditary cancer cohort with up to 11 years of follow-up, this study highlights the clinical value of Singapore's diverse demographic. It also establishes the critical necessity of continuous VUS reassessment. Systematic, long-term VUS tracking is indispensable for optimizing timely interventions and improving cancer prevention. Reclassified variants and cascade testing outcomes. Gene Category & Key Genes Reclassified PVs, n (%) Median Time to Reclassification, yr (Range) Pedigrees with Cascade Testing, n (%) Novel PV Carriers Identified, n Lynch Syndrome ( MLH1, MSH2 ) 9 (14.8%) 1.5 (0.34-6.5) 5 (55.6%) 13 Hereditary Breast/Ovarian ( BRCA1, BRCA2 ) 12 (19.7%) 1.33 (0.22-4.99) 6 (50%) 15 Gastrointestinal Polyposis ( MUTYH, POLE ) 7 (11.5%) 1.89 (0.36-5.94) 0 (0%) 0 Other HRR / Moderate Risk ( ATM, CHEK2, RAD51C, BARD1 ) 13 (21.3%) 2.5 (0.56-6.37) 1 (7.7%) 1 Rare High-Penetrance ( TP53, VHL, NF1, SDHA, SDHB, POT1 ) 9 (14.7%) 1.1 (0.15-3.33) 4 (44.4%) 4 Other genes ( ERCC4, CFTR, RINT1, TET2, FANCA ) 11 (18.0%) 1.61 (0.54-3.13) 0 (0%) 0 Overall Cohort 61 (100%) 1.55 (0.15-6.5) 16 (26.2%) 33

Phase Engineering of Pd–Te Hexagonal Nanoplates for Enhancing Nitrogen Oxidation

Journal of the American Chemical Society Pinlin Wang, Fei Xue, Xubin Ye et al. Jul 01, 2026 DOI: 10.1021/jacs.6c04881

Hard Lewis Base‐Driven Crystallization Control for Efficient All‐Perovskite Tandem Solar Cells

Advanced Materials Yuqi Bao, Jie Zeng, Xia Lei et al. Jul 01, 2026 DOI: 10.1002/adma.73682

ABSTRACT All‐perovskite tandem solar cells (APTSCs) have attracted considerable research interest in recent years due to their higher theoretical efficiencies and broader spectral coverage. Nonetheless, as the bottom narrow‐bandgap cell in APTSCs, tin‐lead (Sn‐Pb) hybrid perovskite solar cells (PSCs) still face challenges of high defect density and poor crystallization morphology, which hinder the further improvement of device performance and long‐term stability. This work proposes a Lewis hard‐basicity amplification strategy that provides additional potential hard‐acid binding sites and promotes coordination with Sn 2+ , thereby enabling defect passivation and regulating crystallization. Ultimately, we achieved a champion power conversion efficiency (PCE) of 23.71% for single‐junction Sn‐Pb PSCs. By integrating 1.77 eV wide‐bandgap perovskites with Sn‐Pb hybrid perovskites, we further fabricated APTSCs with a champion PCE of 29.44%. Both devices retain approximately 80% of their initial efficiency after 1080 h of continuous operation under one‐sun illumination.

Conductive Hydrogels for Exogenous Sensing and Cell Fate Control

Advanced Materials Teuku Fawzul Akbar, Carlos Alejandro Jimenez‐Rodriguez, Railia Biktimirova et al. Jul 01, 2026 DOI: 10.1002/adma.72866

ABSTRACT Next generation technologies linking living systems to computers will require materials built on biology, an approach that may address persistent challenges in stable and multimodal information exchange. Here, we present a semi‐synthetic hydrogel, designed to emulate key features of native extracellular matrix (ECM) while offering electrically tunable functionality. We engineer interactions between sulfated glycosaminoglycans (sGAGs) and a semiconducting organic polymer (poly(3,4‐ethylenedioxythiophene), PEDOT) within a soft hydrogel network (PEDOT:sGAGh). We demonstrate control over the material's nanoarchitecture, electrochemical behavior, and biomolecular interactions. In particular, PEDOT:sGAGh exhibits affinity for bioactive proteins, including growth factors, and allows their release or retention to be modulated by low‐voltage stimulation. This enables electrical control over macromolecular cues for cell differentiation, a capability not found in natural ECM or conventional conductive hydrogels. These functions are achieved with ultra‐low PEDOT content (≈1 wt.%), preserving the hydrogel's tissue‐like softness and high water content. The PEDOT:sGAGh material can be integrated as a bioactive coating on electrodes, or into 3D organic electrochemical transistors (OECTs). Our results position PEDOT:sGAGh as a versatile platform for realizing biohybrid circuits that bridge molecular signaling and solid‐state electronics, thus paving the way for brain‐machine interfaces that operate beyond purely electrical modes of interaction.

Engineering human RNase 7 with an eosinophil RNase segment reveals determinants of cytotoxic and antimicrobial activity

Journal of Biological Chemistry Thi Thanh Quynh Tran, Sacha T. Larda, Cecilia Nieves et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113189

Calendar-year seasonality in colorectal and breast cancer screening and first-time uptake: A 6-year single-center time-series to optimize capacity level-loading (2020–2025).

Journal of Clinical Oncology An-NI Anni Chen, Jia-Chyi Lian, Yun-Kuang Chang et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.321

321 Background: Within-year peaks and troughs in screening utilization can create early-year capacity constraints and late-year underutilization. We quantified month-of-year seasonality in colorectal cancer (CRC) and breast screening and translated it into an operational planning metric for capacity level-loading. Methods: We analyzed monthly screening volumes from January 2020 to December 2025 (72 months) at one hospital. Outcomes were total monthly screens and first screens for CRC and breast screening. Month-of-year effects were estimated using Poisson regression with month indicators and year fixed effects, using March as the reference month. We summarized operational impact using an annual level-loading fraction, defined as the sum of above-mean monthly excess volume divided by annual total volume, representing the proportion of annual volume that would need redistribution from high- to low-volume months to achieve a flat monthly schedule. Results: We observed 36,158 screenings (23,266 CRC; 12,892 breast), mean 502/month. Combined volume peaked in March (mean 810/month; 1.61x mean) and was lowest in December (mean 364/month; 0.73x) (peak-to-trough 2.22). Q4 volume was 41% lower than Q1 (391 vs 662/month). After year adjustment, December remained lower than March (CRC + breast IRR 0.45, 95% CI 0.33–0.61; P < 0.001), with a larger decline for CRC (Dec vs Mar IRR 0.35, 95% CI 0.25–0.49; P < 0.001) than breast (Dec vs Mar IRR 0.70, 95% CI 0.53–0.93; P = 0.013); breast volume was lowest in February (Feb vs Mar IRR 0.67, 95% CI 0.49–0.92; P = 0.012). First screens totaled 5,062 for CRC (21.8%) and 3,105 for breast (24.1%). CRC first screens peaked in February (mean 118.8/month) vs January (34.8/month) (ratio 3.41), whereas breast first screens peaked in December (64.8/month) vs January (29.0/month) (ratio 2.24). The median annual level-loading fraction was 13.4% (range 6.9–24.8) across years. Conclusions: CRC and breast screening utilization showed substantial, reproducible month-of-year seasonality with program-specific first-screen peaks. From a health services perspective, these findings support calendar-aware capacity allocation—protecting early-year CRC first-screen capacity, shifting repeat CRC volume into late-year months, and reserving Q4 breast first-screen slots—to reduce peak-month access constraints and better utilize late-year latent capacity.

Positional Isomer of P3HB by Stereoselective Polymerization of Racemic α-Methyl-β-propiolactone Delivers Polyethylene-like Properties

Journal of the American Chemical Society Ruirui Li, Jun-Jie Tian, Jiyun Nam et al. Jul 01, 2026 DOI: 10.1021/jacs.6c04108

Ultra‐High‐Throughput Discovery of Multifunctional Polyphenolic Coatings on Droplet Microarrays

Advanced Materials Vania Tanda Widyaya, Joaquín E. Urrutia Gómez, Paul Reuß et al. Jul 01, 2026 DOI: 10.1002/adma.73612

ABSTRACT The rapid discovery of functional coatings is vital for advancing technologies in healthcare, energy, and environmental protection, yet it remains limited by the lack of scalable high‐throughput (HT) methods. Here, an ultra‐high‐throughput (UHT) combinatorial strategy is introduced for the miniaturized synthesis and screening of polyamine‐polyphenolic ( PaPp ) coatings (formed in Tris buffer) using droplet microarrays (DMA). Approximately 30 000 coatings were generated from binary and ternary combinations of 51 polyphenols ( Pp ) and 12 polyamines ( Pa ), each produced in 160 nL volumes (<5 mL total reagent use), enabling the rapid identification of hundreds of previously unknown functional materials, including over 225 fluorescent coatings and more than 100 redox‐active, metal‐reducing surfaces. Antibacterial screening uncovered seven coatings with reproducible activity against Pseudomonas aeruginosa , and subsequent validation on macroscale substrates confirmed up to <1‐log colony‐forming unit (CFU) reduction against P. aeruginosa and E. coli . Importantly, five coatings exhibited multiple functionalities, combining surface stability, intrinsic fluorescence, metal‐reducing activity, antibacterial effects, and compatibility with adherent human cells. This UHT approach yields the first comprehensive functionality map of PaPp coatings, revealing previously inaccessible multifunctional materials and demonstrating a scalable strategy for the discovery of surface chemistries with tailored optical, redox, and biological properties.

Tissue-dependent enzymatic control of N-acetyl-β-alanine by PTER

Journal of Biological Chemistry Ruida Li, Sipei Fu, Zhenyu Lyu et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113191

PET-based radiomics as a preoperative predictor of pathologic lymph node metastasis in lung cancer.

Journal of Clinical Oncology Wei-Chih Shen, Chun-Ting Fang, Yi-Han Liao et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.266

266 Background: Lymph node metastasis (LNM) critically influences treatment strategy in lung cancer, as nodal involvement may alter surgical eligibility and the need for multimodality therapy. Preoperative staging relies mainly on CT and PET-CT, which are limited by suboptimal sensitivity and false-positive findings. We therefore developed a prediction model to improve LNM identification and support treatment decision-making. Methods: This study retrospectively enrolled 166 patients with lung cancer who underwent PET-CT for preoperative staging between 2013 and 2020. A total of 175 pathologically confirmed tumors were analyzed at the lesion level, with LNM as the prediction target. To avoid ambiguous lesion-level labeling, patients with multiple synchronous tumors and LNM were excluded. SUV max -based thresholding was conducted to delineate the metabolic tumor volume of a tumor, from which peritumoral and boundary regions were generated. Radiomic features were extracted from every defined region according to the Image Biomarker Standardization Initiative guidelines, using multi-scale discretization. A stratified ten-fold nested cross-validation framework was employed to estimate model performance. In each outer fold, feature selection using recursive feature elimination and model training with a LightGBM classifier were conducted within the inner loop. Final performance metrics were averaged across the outer folds. For clinical deployment, lesion-level predictions were aggregated at the patient level, with a patient classified as high risk for LNM if any tumor was predicted to be positive. Results: At the lesion level, the model achieved a mean AUC of 81.0% ± 10.5%, with an accuracy of 81.1% ± 6.9%, sensitivity of 86.5% ± 19.5%, specificity of 79.6% ± 10.1%, positive predictive value (PPV) of 58.7% ± 10.4%, and negative predictive value (NPV) of 95.3% ± 6.8% across outer folds. At the patient level, aggregation of lesion predictions yielded an accuracy of 80.7%, sensitivity of 85.4%, specificity of 79.2%, PPV of 57.4%, and NPV of 94.3%. Compared with clinical staging (sensitivity 56.1%, NPV 84.5%), the proposed model demonstrated a substantial absolute increase in sensitivity (29.3%) and NPV (9.8%), while maintaining comparable specificity. Conclusions: The proposed PET-based radiomics model demonstrates promising performance for preoperative prediction of LNM. With substantially improved sensitivity and NPV compared with clinical staging, the model may serve as a noninvasive risk-stratification tool to assist in nodal evaluation and treatment planning.

Unlocking Structural Anisotropy by Guest-Symmetry Modulation Strategy to Achieve Giant Birefringence in Molecular Crystals

Journal of the American Chemical Society Chao-Hong Xie, Yuan-Feng Li, Bin-Wen Liu et al. Jul 01, 2026 DOI: 10.1021/jacs.6c06874

Dual‐Quenching Charge Transfer Unlocks Record Nitrate‐to‐Ammonia Photocatalytic Conversion in Redox‐Active Eosin Y Polymers

Advanced Materials Jiayi Zhang, Dingming Chen, Limei Tian et al. Jul 01, 2026 DOI: 10.1002/adma.73686

ABSTRACT Efficient photocatalytic nitrate reduction reaction (NO 3 RR) is vital for mitigating nitrogen pollution and producing green ammonia (NH 3 ). Although organic polymer photocatalysts show great potential for NO 3 RR, they frequently suffer from low charge separation efficiency. This limitation largely comes from the lack of suitable redox‐active moieties incorporated in the polymer photocatalysts toward NO 3 RR. Herein, we embed the redox‐active Eosin Y (EY) into a conjugated polymer backbone to synthesize a series of EY–X polymers (where X = benzene, biphenyl, or fluorene), in which the extended π‐conjugation can promote dual dynamic and static quenching for directional electron transfer. Upon visible‐light excitation, EY forms a long‐lived radical anion (EY •− ) that stores and relays electrons to nitrate, while ground‐state complexation between polymer and nitrate preorganizes the substrate for photoinduced directional electron transfer. This dual‐pathway mechanism extends charge‐separated lifetimes, inhibits recombination, and enhances electron delivery. Consequently, under cocatalyst‐free conditions, the EY–BE polymer achieves a record high NH 3 production of 215 µmol g −1 h −1 . Experimental and computational investigations support the reversible EY/EY •− cycle and the nitrate‐binding ground‐state complex as the origin of activity and selectivity. This work demonstrates a rational strategy leveraging reversible redox‐active chromophores to integrate dual quenching for designing high‐performance NO 3 RR photocatalysts.

Wanted and unwanted modifications of mRNA, and their effect on gene expression and signaling

Journal of Biological Chemistry Ankanahalli N. Nanjaraj Urs, Animesh Dali, Hani S. Zaher Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113314

Cost-effectiveness of population screening for Lynch syndrome and hereditary breast and ovarian cancer syndrome in Singapore.

Journal of Clinical Oncology Sara Tasnim, Joanne Y.Y. Ngeow, Hui Jun Zhou et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.164

164 Background: Hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome (LS) are the most prevalent hereditary cancer syndromes. Population-based germline genetic testing (GT) has been proposed to improve carrier detection beyond family history (FH)-guided approaches, but economic evidence from Asian settings is lacking. We evaluated the cost-effectiveness of population-based GT strategies for HBOC and LS diagnosis in Singapore. Methods: We conducted cost-utility analyses from Singapore's healthcare system perspective with a lifetime horizon using decision trees and Markov models. For HBOC diagnosis, we compared population-based GT for BRCA1/2 , FH-guided GT, and no testing in cancer-unaffected women aged 30 years. For LS diagnosis, we compared population-based GT for MLH1 , MSH2 , MSH6 and PMS2 ; FH-guided GT, and no testing in cancer-unaffected individuals aged 30 years. Both models included cascade testing of first-degree relatives. Confirmed carriers received syndrome-specific enhanced surveillance and risk-reducing interventions. The willingness-to-pay threshold was S$75,000 per quality-adjusted life-year (QALY). Deterministic, probabilistic, and scenario analyses assessed uncertainty. Budget impact analyses estimated the five-year costs of the optimal strategy. Results: Population-based BRCA1/2 testing was the optimal strategy with an ICER of S$50,541/QALY relative to FH-guided BRCA1/2 testing with 99.93% probability of cost-effectiveness and averted one additional cancer per 1,000 women tested. Implementation of population-based BRCA1/2 testing requires an additional annual investment of S$1.69 million and identifies 182 additional BRCA1/2 carriers per annual cohort. For LS diagnosis, population-based GT was not cost-effective (ICER: S$179,564/QALY relative to FH-guided GT). FH-guided GT for LS had an ICER of S$75,210/QALY versus no testing but exhibited substantial decision uncertainty (45.44% vs 54.50% probability of cost-effectiveness), which resolved when cascade testing was extended to second-degree relatives (ICER: S$63,809/QALY). Cost-effectiveness outcomes were highly sensitive to surveillance adherence, cascade testing uptake, and LS prevalence. Conclusions: Population-based GT is cost-effective for BRCA1/2 but not for LS. FH-guided GT for LS approaches cost-effectiveness, particularly when cascade testing is extended to second-degree relatives. Future analyses should evaluate the integration of LS-associated genes into multigene hereditary cancer panels alongside BRCA1/2 to leverage shared infrastructure.

Evidence for Delocalization between <i>o</i> -Carborane and Triphenylethylene via an Alkynyl Bridge

Journal of the American Chemical Society Wen-Hao Li, Man Zhang, Meng-Yao Niu et al. Jul 01, 2026 DOI: 10.1021/jacs.6c07624

Decoupling and <i>De Novo</i> Design of Flexible Polymeric Films for High‐Temperature Triboelectric Sensing and Electromagnetic Shielding

Advanced Materials Kang Yang, Chenchen Liu, Jiang‐Nan Zhao et al. Jul 01, 2026 DOI: 10.1002/adma.73667

ABSTRACT Polymer‐based triboelectric nanogenerators (TENGs) are shining in fields of micro‐energy harvesting and active sensing by virtue of their flexibility and processability. However, thermionic emission and thermal deformation reduce triboelectric output and distort sensing signals, thereby limiting practical applications in high‐temperature environments. Herein, the charge generation and collection units of polymeric TENGs are decoupled for separate de novo design. A dipolar glass polymer, cardo poly(aryl ether) (CPAE), is synthesized with alternating pendant and main‐chain dipoles and bulky, rigid cardo substituent. Aromatic polyphenol‐anchored MXene nanosheets are subsequently crosslinked and sandwiched within thermostable CPAE films, which improves resistance to high‐temperature oxidation. Thanks to the interlayer modulation of MXenes, the total and absorption electromagnetic shielding effectiveness of the resulting film rises by 55% and 195% compared to pristine MXene films, respectively. Even after annealing at 250°C for 24 h, the shielding effectiveness decreases by only ∼1.5%. Moreover, the resulting TENG exhibits an unusual heat‐induced triboelectric enhancement, with an output voltage of 472.2 ± 0.9 V and a power density of 2250.6 ± 27.7 mW/m 2 at 250°C, which compares favorably with most reported polymer‐based TENGs. This work provides a novel technical pathway for flexible electromagnetic protection and self‐powered sensing under extreme operating conditions.